Next, head and neck squamous cell carcinomas (HNSCC) and cervical cancer of unknown primary (CUP) were added to the list of SEC62 overexpressing tumors (Wemmert et al., 2016; Bochen et al., 2017) as were dysplastic cervical lesions (Linxweiler et al., 2016), atypical fibroxanthoma and melanoma (Müller et al., 2019; Müller et al., 2021), mammary carcinoma/invasive ductal breast cancer, vulvar cancer/vulvar intraepithelial neoplasia, cervical cancer/cervical intraepithelial neoplasia (Takacs et al., 2019a; Takacs et al., 2019b; Takacs et al., 2019c) and gastric cancer (Su et al., 2022). This evidence concerns the gene SEC62 and cervical cancer.